2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019...

20
2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY COUNTRY President 360MEDLINK Canada VC/Corporate VC 3E Bioventures United States VC/Corporate VC 3M Company United States CEO 712 North United States Advisor 712 North United States Founder, Chairman and Chief Investment Officer A2A Pharmaceuticals United States CEO and Co-Founder A2A Pharmaceuticals United States CSO Abalone Bio United States CEO Abalone Bio United States VC/Corporate VC AbbVie United States VC/Corporate VC AbbVie United States Angel Investing ABES Venture Partners United States VC/Corporate VC Abingworth Management United States CEO Abreos Biosciences United States Vice President, Corporate Development ACADIA Pharmaceuticals United States Endowment/Foundation Accelerator Life Science Partners United States CEO Accelero Biostructures United States President & CEO Accuitis, Incorporated United States CEO Acquist Therapeutics United States Managing Director ACS Brightedge Fund United States Chief Scientific Officer ACT Genomics Taiwan CFO ACT Genomics Taiwan Principal Financial Officer Actinium Pharmaceuticals United States Chairman and CEO Actinium Pharmaceuticals United States CEO ActoBio Therapeutics Belgium VC/Corporate VC Acuris Partners United States Director of Finance and Administration Adjuvance Technologies United States Chairman, President & CEO Adjuvance Technologies United States CFO Adjuvance Technologies United States VC/Corporate VC Adjuvant Capital United States CEO Aethlon Medical United States VC/Corporate VC Agent Capital United States Angel Investing Agilent Technologies United States VC/Corporate VC Agilent Technologies United States VC/Corporate VC Agilent Technologies United States CEO Ahead Therapeutics Spain

Transcript of 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019...

Page 1: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

2019 BIO Investor Forum Attendee List as of October 8, 2019

TITLE/INVESTOR TYPE COMPANY COUNTRY

President 360MEDLINK Canada

VC/Corporate VC 3E Bioventures United States

VC/Corporate VC 3M Company United States

CEO 712 North United States

Advisor 712 North United States Founder, Chairman and Chief Investment Officer A2A Pharmaceuticals United States

CEO and Co-Founder A2A Pharmaceuticals United States

CSO Abalone Bio United States

CEO Abalone Bio United States

VC/Corporate VC AbbVie United States

VC/Corporate VC AbbVie United States Angel Investing ABES Venture Partners United States

VC/Corporate VC Abingworth Management United States

CEO Abreos Biosciences United States

Vice President, Corporate Development ACADIA Pharmaceuticals United States

Endowment/Foundation Accelerator Life Science Partners United States

CEO Accelero Biostructures United States President & CEO Accuitis, Incorporated United States

CEO Acquist Therapeutics United States

Managing Director ACS Brightedge Fund United States

Chief Scientific Officer ACT Genomics Taiwan

CFO ACT Genomics Taiwan

Principal Financial Officer Actinium Pharmaceuticals United States Chairman and CEO Actinium Pharmaceuticals United States

CEO ActoBio Therapeutics Belgium

VC/Corporate VC Acuris Partners United States

Director of Finance and Administration Adjuvance Technologies United States

Chairman, President & CEO Adjuvance Technologies United States

CFO Adjuvance Technologies United States VC/Corporate VC Adjuvant Capital United States

CEO Aethlon Medical United States

VC/Corporate VC Agent Capital United States

Angel Investing Agilent Technologies United States

VC/Corporate VC Agilent Technologies United States

VC/Corporate VC Agilent Technologies United States CEO Ahead Therapeutics Spain

Page 2: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

CEO AIMM Therapeutics Netherlands CEO AiVita Biomedical United States

Family Office Aleph Capital United States

VC/Corporate VC Alexandria Venture Investments United States

VC/Corporate VC Alignment Ventures United States

CFO Allen Institute For Brain Science United States

Executive Vice President of R&D and CMO Allogene Therapeutics United States Chairman Alpha Cancer Technologies Canada

Chief Executive Officer Alpha Cancer Technologies Canada

VP of Business Development Alpine Immune Sciences United States

Family Office Altamont Pharmaceutical Holdings United States

Family Office Altamont Pharmaceutical Holdings United States

Chief Financial Officer Altimmune United States President and CEO Altimmune United States

VC/Corporate VC Altitude Life Science Ventures United States

CEO Amma Therapeutics United States

Adviser, Business Development Amma Therapeutics United States

CEO Amnicell United States

Founder and Chief Science Officer Amnicell United States VP AMPsource Biopharma United States

CEO AMRA Medical United States

President & CEO Amygdala Neurosciences United States

VC/Corporate VC Andreessen Horowitz United States

Board member Anima Biotech United States

Co-founder and CEO Anima Biotech United States Chief Business Officer Annexon Biosciences United States

Chief Medical & Development Officer Antev United Kingdom

CEO Antev United Kingdom

CEO Antidote Technologies United States

Director - Aon Life Sciences Aon Risk Solutions United States

Senior Vice President Aon Risk Solutions United States

CFO & VP Business Development Aposense Israel

Hedge/Mutual Funds (PM, Buy-Side Research) Aquilo Capital United States

Hedge/Mutual Funds (PM, Buy-Side Research) Aquilo Capital United States

VC/Corporate VC Arch Venture Partners United States

VC/Corporate VC Arch Venture Partners United States

Founder, President & CEO Arcturus Therapeutics United States Director, IR/PR/Marketing Arcturus Therapeutics United States

CFO Arcturus Therapeutics United States

President & CEO Aristea Therapeutics United States

Chief Operating Officer Aristea Therapeutics United States

Chief Medical Officer Aristea Therapeutics United States

VC/Corporate VC Arix Bioscience United States

Page 3: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

VC/Corporate VC ARTIS Ventures United States VC/Corporate VC Artis Ventures United States

VC/Corporate VC Asahi Kasei America United States

VC/Corporate VC Asajes Medical Japan

VC/Corporate VC Asajes Ventures Japan

President & CEO Aspect Biosystems Canada

VC/Corporate VC Asset Management Ventures United States VC/Corporate VC Asset Management Ventures United States

Other Astellas Innovation Management United States

VC/Corporate VC Astellas Innovation Management United States

VC/Corporate VC Astellas Pharma US United States

VC/Corporate VC Astellas Pharma US United States

Other Astellas Pharma US United States VC/Corporate VC Astellas Venture Management United States

Director, Oncology Search & Evaluation AstraZeneca United States

Royalty/Debt Financing ATEL Ventures United States

VC/Corporate VC Atheneos Ventures United States

CEO Attentive Therapeutics United States

CMO Attentive Therapeutics United States CEO Auransa United States

chief scientific officer Auransa United States

Chief Operating Officer Auransa United States

CEO Aurora Bio United States

Founder, CEO Avail Bio United States

CEO Avails Medical United States President & CEO Avisa Pharma United States

President and CEO AxeroVision United States

Angel Investing Band of Angels United States

Venture Philanthropy Barbara Lavery United States

CEO Bastion Biologics United States

CEO BCell Solutions United States

Family Office Beacon Capital United States

Financial Advising Bijan Capital United States

Chief Executive Officer Bilix Korea, Republic of

Partner Bill and Melinda Gates Foundation United States

Editor in Chief BioCentury United States

Senior Editor BioCentury United States Family Office Biocoast Capital United States

Angel Investing BioIdeations United States

Angel Investing BioIdeations United States

Chief Commercial Officer Biolidics Singapore

VC/Corporate VC Biomark Capital United States

VC/Corporate VC Biomark Capital United States

Page 4: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

President & CEO BioMarker Strategies United States Managing Director BioMotiv United States

Director, Technical Operations BioMotiv United States

VC/Corporate VC Bios Partners United States

President/Founder BioSuperior Technology United States

Family Office Biotech Alliances International United States

CEO Bioxceed Innovation Hub United States CEO BioXcel Therapeutics United States

VP, Business Development BioXcel Therapeutics United States

COO Bipharm Russian Federation

Chief Medical Officer Bird Rock Bio United States

President & CEO Bird Rock Bio United States

CFO Bird Rock Bio United States VP, Corporate Affairs BlackThorn Therapeutics United States

President and COO BlackThorn Therapeutics United States

CEO Bloom Science United States

Angel Investing Bohe Angel Fund China

Family Office Borex Capital United States

VC/Corporate VC Boryung Holdings Korea, Republic of VC/Corporate VC Boryung Holdings Korea, Republic of

VC/Corporate VC Boryung Holdings Korea, Republic of

VC/Corporate VC Boryung Holdings Korea, Republic of

VC/Corporate VC Boryung Holdings Korea, Republic of

Hedge/Mutual Funds BOSON Capital Partners United States

CEO Boundless Bio United States VC/Corporate VC Brace Pharma Capital United States

VC/Corporate VC Brace Pharma Capital United States

VC/Corporate VC Brace Pharma Capital United States

VC/Corporate VC Brain Trust Accelerator Fund United States

Co-Founder and CEO Brava Diagnostics United States

Chief Executive Officer Breakthrough Genomics United States

Associate, Asset Acquisition BridgeBio Pharma United States

Other BridgeBio Pharma United States

CEO Bridgene Biosciences United States

EVP BridGene Biosciences United States

External Operations Lead Bristol-Myers Squibb Company United States Exec Director, Business Development Transactions Bristol-Myers Squibb Company United States Sr. Director, Business Development Bristol-Myers Squibb Company United States

Global Search & Evaluation Lead, Fibrosis Bristol-Myers Squibb Company United States

Associate Director, Business Development Bristol-Myers Squibb Company United States

Sell-Side Research Brookline Capital Markets United States

Sell-Side Research BTIG United States

Page 5: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

Investment Bank BTIG United States VP Strategy and BD Bugworks Research United States

International Business Development Business France United States

President & CEO California Institute For Regenerative Medicine United States

Associate Director, Portfolio Development & Review California Institute For Regenerative Medicine United States

Executive Director Cambia Grove United States

analyst Canaccord Genuity United States Royalty/Debt Financing Canadian Imperial Bank of Commerce Canada

Chief Finance Officer Cantabio Pharmaceuticals United States

Chief Executive Officer Cantabio Pharmaceuticals United States

VC/Corporate VC Capital Family Office United States

CEO Cardiogas Technologies Japan

President & CEO Caribou Biosciences United States Chief Business Officer Caribou Biosciences United States

Family Office Cato BioVentures United States

VC/Corporate VC CEC Capital United States

VC/Corporate VC CEC Capital United States

Chief Executive Officer Cell Care Therapeutics United States

VP, Corporate Development Celularity United States VC/Corporate VC Cenova Capital United States

CEO Century Therapeutics United States

CEO Cerevance United States

CSO CerSci Therapeutics United States

VP, Finance & BD CerSci Therapeutics United States

CEO CerSci Therapeutics United States Principal Financial Officer Cesca Therapeutics United States

Angel Investing Chaperone Investment United States

Other China Grand United States

Senior Life Sciences Underwriting Specialist Chubb United States

Hedge/Mutual Funds CI Investments Canada

VC/Corporate VC Cipla United States

CEO Circle Pharma United States

CEO Circumvent United States

Director Business Development City of Hope United States

Chief Executive Officer Clearbridge BSA Singapore

Co-Founder & CEO Click Therapeutics United States

Director Clinical Network Services United Kingdom President & CEO CODA Biotherapeutics United States

CEO CohBar United States

Chief Operating Officer CohBar United States

Executive Director Comcast United States

Chief Executive Officer Common Pharma United States

Co-Founder & CEO Contraline United States

Page 6: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

Chief Technology Officer Contraline United States President Correlia Biosystems United States

Co-founder, CTO Correlia Biosystems United States

CFO Cortexyme United States

EVP BD Corvidia Therapeutics United States

CEO Courier Therapeutics United States

VC/Corporate VC Cove Fund II United States Investment Bank Coventry Enterprises United States

VC/Corporate VC Cowin Capital United States

VC/Corporate VC Crosswave Management China

VC/Corporate VC Crosswave Management United States

VC/Corporate VC CRV United States

VC/Corporate VC CSC Leasing United States President & CEO Cue Biopharma United States

Chief Business Officer Cydan II United States

Vice President of BioPharma Programs Cystic Fibrosis Foundation United States

President & CEO CytoDyn United States

CEO Cytonus Therapeutics United States

VP Corporate Affairs Cytovia Therapeutics United States Chairman & CEO Cytovia Therapeutics United States

Chief Executive Officer Da Volterra France

Family Office Dabar Investment Associates United States

Cofounder Dalriada Therapeutics Canada

CEO Dalriada Therapeutics Canada

Co-founder Dalton Bioanalytics United States Hedge/Mutual Funds (PM, Buy-Side Research) Dalton Investment United States

VC/Corporate VC Danaher Life Sciences United States

President & CEO Daré Bioscience United States

VC/Corporate VC Data Collective Venture Capital United States

VC/Corporate VC DAYLI Partners Korea, Republic of

VC/Corporate VC DCVC Bio United States

Partner Deallus Consulting United States

Head of Strategic Partnering Debiopharm International S.A. Switzerland

CEO Deciduous Therapeutics United States

Founder, President and CEO Decoy Biosystems United States

Chief Business Officer Decoy Biosystems United States

President Deep Lens United States VC/Corporate VC Defta Partners United States

VC/Corporate VC Defta Partners United States

VC/Corporate VC Defta Partners United States

CEO & Founder DelNova United States

Vice President Delta-Fly Pharma Japan

Vice President, BD Director Delta-Fly Pharma Japan

Page 7: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

Chief Business Officer Demuris United Kingdom VC/Corporate VC DHVC United States

CEO Dia-beat-it United States

VC/Corporate VC DigiTx Partners United States

CEO DNALite Therapeutics United States

VC/Corporate VC Dolby Family Ventures United States

Family Office Dorset Capital United States CEO DOTBIO Singapore

Hedge/Mutual Funds DoubleLine Capital United States

CEO Drusolv Therapeutics United States

Chief Executive Officer Dyadic International United States

VC/Corporate VC Dynamk Capital United States

CEO / Co-Founder Dyve Biosciences United States Global Innovation & Alliance Team Leader EA Pharma Japan

Royalty/Debt Financing East West Bank United States

Senior Manager Economic Development Agency Brandenburg Germany

VP, Investor Relations Edesa Biotech Canada

Chief Executive Officer Edesa Biotech Canada

VC/Corporate VC Eisai Japan Co-Founder & CEO Elevian United States

CEO Elex Biotech United States

COO Business Development Eli Lilly United States

Senior Advisor, External Innovation Eli Lilly and Company United States

Director- Digital Health, External Innovation Eli Lilly and Company United States

Venture Philanthropy Emerson Collective United States CEO EngineBio United States

President and CEO Engrail Therapeutics United States

CEO Ensysce Biosciences United States

CEO EnterTroy Bio United States

VP Medical Affairs EnterTroy Bio United States

Director of Business Development Epic Sciences United States

Chief Medical Officer Epic Sciences United States

Senior Director of Innovation Epilepsy Foundation United States

President and Chief Business Officer Equillium United States

Family Office Esousa Holdings United States

President and CFO Espero BioPharma United States

CEO ethris GmbH Germany Senior Vice President of Corporate Strategy Eureka Therapeutics United States

New Business Development, Director Evaluate United States

Chief Executive Officer Exicure United States

CEO Exotome United States

CEO Exxel Pharma United States

CEO Facile Therapeutics United States

Page 8: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

CEO Fellow Health United States Director of Health Fellow Health United States

Founder & CEO FenoLogica Biosciences United States

President and CEO First Light Diagnostics United States

Other FMG Ventures United States

VC/Corporate VC FMG Ventures United States

President and CEO Foresee Pharmaceuticals Taiwan Entrepreneur in Residence Fortress Biotech United States

Business Development Fortress Biotech United States

VC/Corporate VC Fosun Private Equity United States

VC/Corporate VC F-Prime Capital Partners United States

VC/Corporate VC Fujifilm Diosynth Biotechnologies United States

VC/Corporate VC G4S Capital United States CEO Galimedix Therapeutics United States

Chief Scientific Officer Galimedix Therapeutics United States

Advisor Galimedix Therapeutics United States

VC/Corporate VC GE Ventures United States

CEO Gel4Med United States

VC/Corporate VC Genoa Ventures United States CEO & Founder GLAdiator Biosciences United States

VC/Corporate VC Global Neurohealth Ventures United States

President & CEO GlobalConnectworks Canada

SVP Pharmaceuticals & Medical Devices GlobalData United States

BD Executive & Strategic Alliance Manager GlobalData United States

Researcher GlyTech Japan CEO Golden Biotechnology Taiwan

VC/Corporate VC GreenSky Capital United States

CEO Greenwich LifeSciences United States

VC/Corporate VC Grey Sky Venture Partners United States

Associate, Investment Banking H.C. Wainwright & Company United States

Director, Investment Banking H.C. Wainwright & Company United States

vice president H.C. Wainwright & Company United States

VC/Corporate VC H.I.G. Capital United States

Chief Operating Officer Halloran Consulting Group United States

CEO Halo Biosciences United States

Family Office Hannol Ventures United States

Chief Business Officer Haystack Sciences United States VC/Corporate VC Hbm Partners Switzerland

Royalty/Debt Financing HCM Healthcare Capital Management United States

Royalty/Debt Financing HealthCare Royalty Partners United States

COO Heartseed Japan

VC/Corporate VC HEDA Ventures United States

VC/Corporate VC Helicase Venture United States

Page 9: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

VC/Corporate VC Helix Ventures United States Managing Director Helixmith Korea, Republic of

CFO Helixmith Korea, Republic of

VC/Corporate VC Hemi Ventures United States

Managing Director Hercules Capital United States

Royalty/Debt Financing Hercules Capital United States

VC/Corporate VC Hermes Life Science Ventures United States Chief Executive Officer Hibernaid United States

Founder, CBDO & CSO Histogen United States

Chairman & CEO Histogen United States

VC/Corporate VC Hone Capital United States

Science Director Honeylab New Zealand

President Hyaloric Biotech United States President Hygieia Biological Laboratories United States

CAO IACTA Pharmaceuticals United States

CEO IACTA Pharmaceuticals United States

Venture Philanthropy Iaso Ventures United States

VC/Corporate VC Illumina Accelerator United States

VC/Corporate VC Illumina Accelerator United States Partner Illumina Ventures United States

VC/Corporate VC Illumina Ventures United States

VC/Corporate VC Illumina Ventures United States

CEO Ilya Pharma Sweden

President and CEO ImmunoMet Therapeutics United States

Chief Innovation Officer Immunophotonics United States Commercial Advisor Immupharma United Kingdom

President & CEO Impact Therapeutics China

Chief Business Officer Impel NeuroPharma United States

Director Finance IMV Canada

VC/Corporate VC IN CAPITAL China

VC/Corporate VC Inbio Ventures Russian Federation

Chief Business Officer InCarda Therapeutics United States

VC/Corporate VC INCJ Japan

Chief Executive Officer Incysus Therapeutics United States

Independent Advisor Independent Advisor United States

Content Marketing Director Informa United States

President & CEO InMed Pharmaceuticals Canada Founder, President & CBO Innovate Biopharmaceuticals United States

CEO Intabio United States

VC/Corporate VC Integral Group Taiwan

President & CEO Interface Biologics Canada

President & CEO Interpace Diagnostics Group United States

CEO InterVenn Biosciences United States

Page 10: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

Board Member InterVenn Biosciences United States Chief Business Officer InterVenn Biosciences United States

CPO InterVenn Biosciences United States

VC/Corporate VC Intuitive United States

President InveniAI United States

CEO & Founder Inversago Pharma Canada

CEO & Co-Founder Invivo Sciences United States Royalty/Debt Financing IPF Partners United States

CEO and CTO ISOThrive United States

CEO Jaan Biotherapeutics United States

VC/Corporate VC JHBio United States

VC/Corporate VC Johnson & Johnson Development United States

VC/Corporate VC Joyance Partners United States New Technology Acquistion JT Pharma United States

VC/Corporate VC Julz United States

Venture Philanthropy Juvenile Diabetes Research Foundation United States

VC/Corporate VC KB Financial Group United States

VC/Corporate VC KB Financial Group Korea, Republic of

Chief Commercial Officer, VP Operations Kedalion Therapeutics United States Executive Director of Business Development Kelun Pharmaceuticals United States

SVP, Strategy & External Affairs Kezar Life Sciences United States

Chief Executive Officer Kezar Life Sciences United States

Senior Director, Finance & BD Kezar Life Sciences United States

SVP, BD & Corporate Communications Kineta United States

Chief Executive Officer Kineta United States Hedge/Mutual Funds Kingsford Capital Management United States

CEO Kinoxis Therapeutics Australia

President Kissei America United States

Chief Executive Officer Kleo Pharmaceuticals United States

COO & CFO Kleo Pharmaceuticals United States

President KPI Therapeutics United States

President Kyorin USA United States

VC/Corporate VC Kyoto University Japan

Greater China Managing Partner L.E.K. Consulting China

VC/Corporate VC Laguna Ventures United States

VC/Corporate VC Laguna Ventures United States

Angel Investing Laguna Ventures United States Chairman, Founding Director Lagunita BioSciences United States

Chairman of the Board, President and CEO Landos Biopharma United States

Program Director Landos Biopharma United States

VC/Corporate VC Laurel Venture Capital China

Executive Vice President & CSO LaVoieHealthScience United States

President & CEO LaVoieHealthScience United States

Page 11: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

SPARK FLI Program Manager Leibniz Institute on Aging Germany Vice President, Explorations in Global Health Leidos United States

Co-founder and CEO Lempo Therapeutics Israel

Chief Business Officer Lexent Bio United States

Angel Investing Life Science Angels United States

VC/Corporate VC Lilly Asia Ventures China

VC/Corporate VC Lilly Asia Ventures United States Family Office Lincoln Park Capital United States

Family Office Lincoln Park Capital United States

President LIPAC Oncology United States

Chief Scientific Officer Locana United States

Managing Director, Global Head of Biopharma Locust Walk United States

Senior Vice President, Financing Locust Walk United States Regional Sales Manager Lonza Group United States

Manager, Business Development Lonza Group United States

Senior Director, General Manager, Ibex Lonza Group Switzerland

Partner LSA United States

VC/Corporate VC Lumira Ventures Canada

VC/Corporate VC Lumira Ventures Canada Chief Executive Officer Lung Therapeutics United States

Chief Financial Officer Lunit Korea, Republic of

CEO Lunit Korea, Republic of

CEO Lupa Bio United States

VC/Corporate VC Lyfe Capital United States

VC/Corporate VC Lyfe Capital United States VC/Corporate VC Lyfe Capital United States

VC/Corporate VC Lyfe Capital United States

VC/Corporate VC Lyfe Capital China

VC/Corporate VC Lymo Ventures United States

CEO Lynx Biosciences United States

VC/Corporate VC LYZZ Capital Advisors United States

VC/Corporate VC LYZZ Capital Advisors United States

Director MacDougall Biomedical Communications United States

Senior Vice President MacDougall Biomedical Communications United States

CFO MAIA Biotechnology United States

CEO Mammoth Biosciences United States

President/CEO Mandalmed United States CEO Mantra Bio United States

Hedge/Mutual Funds Matthews Asia United States

Hedge/Mutual Funds Matthews Asia United States

Hedge/Mutual Funds Matthews International Capital Management United States

President & CEO MaxCyte United States

Other Mayewell Capital United States

Page 12: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

Other MDB Capital Group United States Other MedImmune Ventures United States

Founder & Chief Medical Officer Medsavana Spain

CEO Membio Canada

Executive Director - Business Development Merck United States

Head, Pacific BD&L Hub and President, MRL Ventures Fund Merck United States

Director of Business Development & Licensing Merck United States Executive Director, Business Development & Licensing Merck United States

Head, BioPharma External Innovation Merck United States

Co-founder, Co-CEO Metcela Japan

Vice President Metcela Japan

CEO MetVital United States

Advisor MicroRadical 360 India VC/Corporate VC Milestone Capital China

Associate Director Mitsubishi Tanabe Pharma United States

VC/Corporate VC Mitsui & Co. Global Investment United States

Consultant MMSC Canada

CEO Molecular Theranostics United States

Co-founder, CSO Molecular Theranostics United States Angel Investing Momentum Biotech United Kingdom

Associate Commercialisation Manager Monash University Australia

Board Member Morphocell Technologies Canada

Founder Morphocell Technologies Canada

partner Morrison & Foerster United States

Partner Morrison & Foerster United States Partner Morrison & Foerster United States

VC/Corporate VC MPM Capital United States

Angel Investing MSQ Ventures United States

VC/Corporate VC MSQ Ventures United States

Executive Director MUSC Foundation for Research Development United States

VC/Corporate VC MyBioGate United States

Senior Vice President Clinical Development Mycovia Pharmaceuticals United States

CEO Mycovia Pharmaceuticals United States

SVP, Commercialization Mycovia Pharmaceuticals United States

President & CEO Nammi Therapeutics United States

VC/Corporate VC Nan Fung Life Sciences United States

VC/Corporate VC Nan Fung Life Sciences United States VC/Corporate VC NanoDimension United States

CCO Nanostics Canada

CEO Nanostics Canada

CEO NaNotics United States

Program Director National Institutes of Health United States

Small Business Program Coordinator National Institutes of Health United States

Page 13: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

Professor and Associate Dean National Taiwan University College of Medicine Taiwan President, Chief Executive Officer & Chief Financial Officer Navidea BioPharmaceuticals United States

Director, Life Sciences, Regulatory Navigant Consulting United States

Chief Executive Officer Navigen Pharmaceuticals United States

Business Development / Attorney NB Health Laboratory Japan

President NB Health Laboratory Japan

VC/Corporate VC NCL Technology Ventures United Kingdom VC/Corporate VC NCL Technology Ventures United States

Strategic Advisor NDA Group Sweden

Principal Consultant NDA Group Sweden

Chairman Nelum United States

CEO CMO NeOnc Technologies United States

Co-Founder/Executive Chairman Neumentum United States Chief Executive Officer Neumentum United States

President & CEO NeuroBo Pharmaceuticals United States

CEO Neurocycle Therapeutics United States

CEO & Managing Director Neuroscientific Biopharmaceuticals Australia

VC/Corporate VC New Enterprise Associates United States

Senior Director of Bio Business Development and Str. New Orleans Business Alliance United States Principal Consultant New5win United States

Strategic Marketing Analyst Nikon Instruments United States

Angel Investing Nivagen Pharmaceuticals United States

Chief Business Officer Nkarta Therapeutics United States

Chief Medical Officer Nkarta Therapeutics United States

Sell-Side Research Nomura Instinet United States Senior Director, Investments North Carolina Biotechnology Center United States

VC/Corporate VC Northern Light Venture Capital United States

Co-Founder, President, CSO Novelogics Biotechnology Canada

VC/Corporate VC Novo Ventures United States

VC/Corporate VC Novo Ventures United States

Business Development Novotech Australia

Director Business Development Novotech Australia

CEO Nucleus Network Australia

Business Development Manager Nucleus Network Australia

Chief Business Officer NuvOx Pharma United States

VC/Corporate VC OCV United States

CEO Okava Pharmaceuticals United States Family Office Olive Tree Capital United States

VP, Business Development Omada Health United States

CEO and President Oncolytics Biotech Canada

Chief Financial Officer Oncolytics Biotech Canada VP, Investor Relations & Corporate Communications Oncolytics Biotech United States

Page 14: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

CEO Oncolyze United States COO Oncolyze United States

Chief Medical Officer Oncolyze Therapeutics United States

CEO Oncomatryx Biopharma Spain

CEO OncoSenX United States

Chief Executive Officer Opiant Pharmaceuticals United States Senior Director, Investor Relations & Communications Opiant Pharmaceuticals United States Consultant Opus Biotech Communications United States

Chief Executive Officer Oragenics United States

Hedge/Mutual Funds Oresund Capital United States

Director of Operations Orion Biotechnology Canada

Chief Medical Officer Orion Biotechnology Canada

Chief Financial Officer OrphoMed United States Founder & CSO OrphoMed United States

CEO Orthopaedic Research and Education Foundation United States

President and CEO OrthoTrophix United States

VC/Corporate VC OSF Healthcare Ventures United States

VC/Corporate VC Otsuka Pharmaceutical Japan

Royalty/Debt Financing Oxford Finance United States

CEO Pacylex Pharmaceuticals Canada

Hedge/Mutual Funds Palo Alto Investors United States

Hedge/Mutual Funds Palo Alto Investors United States

Hedge/Mutual Funds Palo Alto Investors United States

VC/Corporate VC Panacea Venture Healthcare United States

Founder, Kinvac Innovations LLP Panjab University India VICE CHANCELLOR Panjab University India

ASSOCIATE PROFESSOR Panjab University India

VC/Corporate VC Pappas Capital United States

VC/Corporate VC Pappas Ventures United States

CEO Paras Biopharmaceuticals Finland Oy Finland

Family Office Perseverance Capital United States

CEO Phanes Therapeutics United States

VP, Business Development & Operations PharmaDirections United States

VC/Corporate VC Pharmstandard JSC Russian Federation

CEO PHENOMIC AI Canada

CSO PHENOMIC AI Canada

President & CEO Phosplatin Therapeutics United States Executive Vice President Phosplatin Therapeutics United States

Vice President Phosplatin Therapeutics United States

VC/Corporate VC Pivotal BioVenture Partners United States

VC/Corporate VC Pivotal BioVenture Partners United States

VC/Corporate VC Pivotal BioVenture Partners United States

Page 15: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

VC/Corporate VC Pivotal BioVenture Partners United States Angel Investing Pivotal BioVenture Partners United States

Family Office PoC Capital United States

Investment Bank Point Sur Investors United States

Investment Bank Point Sur Investors United States

VC/Corporate VC Premier Partners Korea, Republic of

VC/Corporate VC Presidio Partners United States VC/Corporate VC Prevail Partners United States

VC/Corporate VC Prevail Partners United States

VC/Corporate VC Prevail Partners United States

VC/Corporate VC Primer Capital Russian Federation

Project Lead Privo Technologies United States

CEO Proteina Korea, Republic of VC/Corporate VC Qiming Venture Partners USA United States

President & COO Quadriga Biosciences United States

VC/Corporate VC Quadriga Biosciences United States

VC/Corporate VC Quan Capital China

Global Corp. Strategy & Business Development Rakuten Medical Japan United States

VC/Corporate VC RBV Capital Russian Federation VC/Corporate VC RBV Capital Russian Federation

CEO Rejuvenation Technologies United States

VC/Corporate VC Relentless Pursuit Partners Canada

VC/Corporate VC Remiges Ventures United States

VC/Corporate VC Remiges Ventures United States

VC/Corporate VC Remiges Ventures Japan VC/Corporate VC Remiges Ventures United States

VC/Corporate VC Remiges Ventures Japan

VC/Corporate VC Remiges Ventures Japan

Venture Philanthropy Research Bridge Partners United States

President & CEO Resverlogix Corporation Canada

President and CEO Retrotope United States

Chief Executive Officer Riptide Bioscience United States

VC/Corporate VC Roche Venture Fund United States

CEO RubrYc Therapeutics United States

VP, Technology RubrYc Therapeutics United States

EVP Program Management SAB Biotherapeutics United States

Chief Financial Officer, EVP SAB Biotherapeutics United States VC/Corporate VC Samsung Bioepis Korea, Republic of

VC/Corporate VC Samsung Venture Investment Corporation Korea, Republic of

VC/Corporate VC Sanderling Ventures United States

VC/Corporate VC Sandhill Angels United States

VC/Corporate VC Sanofi United States

VC/Corporate VC Santen Incorporated United States

Page 16: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

VC/Corporate VC Santen Pharmaceutical United States VC/Corporate VC Santen Pharmaceutical United States

VC/Corporate VC Santen Ventures United States

President and CEO Sapience Therapeutics United States

Head, Business Development Satellos Bioscience Canada

President Satellos Bioscience Canada

President & CEO Satsuma Pharmaceuticals United States CFO Satsuma Pharmaceuticals United States

VC/Corporate VC Satter Medical Technology Partnership United States

CEO SCIBAC United States

Angel Investing Science Futures United States

Head of Corporate Communications Seelos Therapeutics United States

Chief Business Officer SEngine Precision Medicine United States Development SENS Research Foundation United States

CSO Senti Biosciences United States

CEO and Co-Founder Sentien Biotechnologies United States

Vice President, Business Development SerImmune United States

Chief Executive Officer Serimmune United States

Chief Executive Officer SFA Therapeutics United States VC/Corporate VC Shanghai Henlius Biotech United States

Vice President, Corporate Development ShareVault United States

Business Development ShareVault United States

VC/Corporate VC Shenzhen Salubris Pharmaceuticals United States

President Shifa Biomedical Corporation United States

Chairman Shinkei Therapeutics United States VC/Corporate VC Simcere Pharmaceutical Group United States

VC/Corporate VC Sinar Mas Technology United States

VC/Corporate VC Sinar Mas Technology United States

President-CEO Siragen Pharmaceuticals United States

CEO Sisu Pharma United States

CEO SmartPharm Therapeutics United States

General Partner Sofinnova Ventures United States

VC/Corporate VC Sofinnova Ventures United States Sr. Director, Corporate & Business Development Spectrum Pharmaceuticals United States Vice President, Corporate and Business Development Spectrum Pharmaceuticals United States

CEO SpinalCyte United States

President and CEO Splash Pharmaceuticals United States VC/Corporate VC SPRIM Ventures Singapore

VC/Corporate VC SR One United States

Program Manager Stanford SPARK Program United States

Fellow Stanford University United States

Page 17: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

VC/Corporate VC StarLink Capital United States VC/Corporate VC StartUp Health United States

Angel Investing Steel Wolf Ventures United States

Executive Vice President Sterling Bay United States

Director of Leasing Sterling Bay United States

Director of Life Sciences Sterling Bay United States

Chief Executive Officer SteroTherapeutics United States CEO Structure Based Design United States

Chief Executive Officer Summit Therapeutics United Kingdom

VP Corporate Development and Strategy Surrozen United States

CEO Surrozen United States

Family Office SWP United States

CEO Symvivo Canada President & CEO SynDevRx United States

Chief Business Officer SynDevRx United States

Director, Investor Relations Synthetic Biologics United States

CEO & CFO Synthetic Biologics United States

CEO SyntheX United States

VC/Corporate VC Taiho Ventures United States VC/Corporate VC Taiho Ventures United States

VC/Corporate VC Taiho Ventures United States

VC/Corporate VC Taiwania Capital Taiwan

VC/Corporate VC Takeda Ventures United States

Family Office Talfinium Investments United States

Product Manager Tampere University Finland CEO TargetGene Biotechnologies Israel

Angel Investing Tech Coast Angels United States

Executive Director & Associate Vice President Technology Venture Commercialization United States

CEO TEGA Therapeutics United States

Sr. Director , Business Operations Teikoku Pharma USA United States

Founder, Chief Executive Officer Tempo Therapeutics United States

Chief Business Officer Terran Biosciences United States

Corporate Development Terumo BCT United States

Sell-Side Research The Benchmark Company United States

Venture Philanthropy The Leukemia & Lymphoma Society United States

Managing Partner The Money Channel NYC United States

Chief Business Development Officer The Money Channel NYC United States Life Science Ventures The University of Chicago United States

Assistant Professor The University of Texas MD Anderson United States

Chairman of the Board TheraTarget United States

Director, Business Development ThinkCyte Japan

SVP ThinkCyte Japan

Executive ThromboTherapeutics United States

Page 18: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

President & CEO Tiberend Strategic Advisors United States CEO Tierra Biosciences United States

CEO TIGAR Health United States

Chief of Strategy and Finance, Founder TIGAR Health United States

Managing Director Torreya United States

Associate Torreya United States

Partner Torreya United States VC/Corporate VC Tosoh USA United States

Founding Partner, President & CEO Traffic Therapeutics United States

President & CEO Tranquis Therapeutics United States

Chief Business Officer Tranquis Therapeutics United States

VC/Corporate VC TransPacific Venture Capital Partners United States

CEO Trilogy Therapeutics United States Angel Investing Triple Ring Technologies United States

CEO Triursus Therapeutics United States

Chief Executive Officer TrovaGene United States

Chief Scientific Officer TrovaGene United States

CEO True Bearing Diagnostics United States

Business Development Officer Tulane University School of Medicine United States Senior Market Research Associate U.S. Pharmacopeial United States

Interim Assoc. Vice Chancellor-Executive Director UC Davis-Office of Research United States

Alliance Manager UCSF United States

CEO Ultivue United States

Family Office Ultreum Capital United Arab Emirates

Executive Director University of California United States Biopharma Program Coordinator University of California, Davis United States

Associate Director University of California, Davis United States

Executive Director, Office of Strategic Alliances University of California, San Francisco United States

Professor University of Colorado Anschutz Medical Campus United States

Senior Director - Business Development University of Michigan United States

Director SPARK Norway University of Oslo Norway

Researcher University of Oslo Norway

Licensing Specialist University of Texas at Austin United States

Manager, Strategic Industry Ventures University of Texas, MD Anderson Cancer Center United States

Director of Strategy University of the Sunshine Coast Australia

Director of Tsukuba Clinical Research and Development Organization University of Tsukuba Japan

Assistant Professor University of Tsukuba Japan New Ventures Manager University of Utah TVC United States

CEO Univfy United States

CEO Unnatural Products United States

CSO Unnatural Products United States

Assistant Professor Unversity of Tsukuba Japan

Financial Advising Valeant Advisors United States

Page 19: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

Chief Executive Officer Valitor United States President and CEO Valley Fever Solutions United States

CEO Valtari Bio United States

Financial Advising VantagePoint Capital Partners United States

CEO Vaporox United States

Founder & CEO Varsona Pharmaceuticals United States

SVP, Corporate Development VelosBio United States VC/Corporate VC venBio United States

VC/Corporate VC venBio Partners United States

Business Development Venture Valuation Switzerland

VC/Corporate VC Vertex Venture Holdings United States

VC/Corporate VC Vertex Ventures United States

President & CEO Vida Strategic Partners United States President & CEO viDA Therapeutics Canada

Senior Strategic Advisor Vigeo Therapeutics United States

President & CEO Vigeo Therapeutics United States

Chief Executive Officer Viramal Limited United Kingdom

Founder & CEO Vistara Bioscience United States

CEO VitriVax United States VC/Corporate VC Vivo Capital United States

VC/Corporate VC Vivo Capital United States

VC/Corporate VC Vivo Capital United States

VC/Corporate VC Vivo Capital United States

CEO VM Oncology United States

Professor Vona Oncology United States Royalty/Debt Financing Voya Financial United States

Chairman & CEO Vybion United States

VC/Corporate VC W Global Capital United States

Endowment/Foundation WARF Therapeutics United States

Endowment/Foundation Washington Research Foundation United States

Hedge/Mutual Funds WBB Securities United States

Hedge/Mutual Funds WBB Securities United States

Chief Scientific Officer Wenbli Therapeutics United States

VC/Corporate VC Westlake Ventures United States

Corp Affairs and Investor Relations Wheelhouse United States

VC/Corporate VC WI Harper Group United States

VC/Corporate VC WI Harper Group United States VC/Corporate VC WI Harper Group United States

Family Office Wu Capital United States

Co-Founder and Executive Chairman xCella Biosciences United States

VC/Corporate VC Xeraya Capital Malaysia

VC/Corporate VC Xeraya Capital Life Venture Malaysia

President & Chief Executive Officer Xoc Pharmaceuticals United States

Page 20: 2019 BIO Investor Forum Attendee Listgo.bio.org/rs/490-EHZ-999/images/2019 BIF Attendee List.pdf2019 BIO Investor Forum Attendee List as of October 8, 2019 TITLE/INVESTOR TYPE COMPANY

CEO Xontogeny United States CBO X-Therma United States

CEO X-Therma United States

VC/Corporate VC Y Combinator United States

VC/Corporate VC YCombinator United States

Co-Founder Yiviva / Yale United States

VC/Corporate VC Yonjin Capital United States VC/Corporate VC Yuhan USA United States

VC/Corporate VC Yuhan USA United States

Chief Business Officer Zenith Epigenetics United States

CEO Zenopharm United States

VC/Corporate VC ZGC Capital United States

Financial Advising ZJ Future United States VC/Corporate VC ZJ Future United States